Anteris Technologies Global Corp. — Director's Dealing 2007

Dec 16, 2007

Innovative BioMedical Devices bioMD Limited ABN 35 088 221 078

Level 11, 225 St Georges Terrace Perth, Western Australia 6000 PO Box 7209, Cloisters Square Western Australia 6850

Telephone (08) 9262 6777 Facsimile (08) 9322 3433 www.biomd.com.au

==> picture [50 x 33] intentionally omitted <==

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 3 pages

17 December 2007

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

Re: Appendix 3Y – Change in Director’s Interest Notice

The Directors of bioMD Ltd wish to advise of changes to the notifiable interests of directors, in accordance with Listing Rule 3.19A.1 and section 205G of the Corporations Act.

Please refer to the ‘Appendix 3Y’ attached for details of changes in holdings due to the allotment of shares and options under the Prospectus dated 22 August 2007. Shareholder approval was sought and given at the general meeting held on 2 October 2007 in relation to this issue of shares/options to directors.

Yours faithfully

==> picture [114 x 86] intentionally omitted <==

CAROLINE L BENTLEY Company Secretary

APPENDIX 3Y CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 055 221 078 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Robert Scott

Date of last notice: 7 May 2007

PART 1 – Change of director's relevant interests in securities

Direct or indirect interest: Indirect Nature of indirect interest: Mr Scott is a director of a company holding BOD Date of change: 14 December 2007

No. of securities held prior to change: Ordinary shares - 275,000 Options expiring 30 Aug 2010 at 25 cents each – Nil. Class: Listed ordinary shares (BOD) Options expiring 30 Aug 2010 at 25 cents each Number acquired: 106,750 shares and 427,000 options Number disposed: N/A Value/Consideration: $21,350 No. of securities held after change: Ordinary shares - 381,750 Options expiring 30 Aug 2010 at 25 cents each – 427,000 Nature of the change: Rights Issue subscription

PART 2 – Change of director’s interests in contracts

Details of contract: None Applicable

Nature of interest: Name of registered holder: (if issued securities) No. and class of securities to which interest relates: Interest acquired: Interest disposed: Value/Consideration: Interest after change:

APPENDIX 3Y CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 055 221 078

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Robert Towner

Date of last notice: 10 August 2007

PART 1 – Change of director's relevant interests in securities

Direct or indirect interest: Direct / Indirect Nature of indirect interest: Mr Towner is a director of a company holding BOD Date of change: 14 December 2007

No. of securities held prior to change: Ordinary shares–10,690,000 (indirect), 150,000 (direct) Options expiring 30 Aug 2010 at 25 cents each – Nil. Class: Listed ordinary shares (BOD) Options expiring 30 Aug 2010 at 25 cents each Number acquired: 375,000 shares and 1,500,000 options (indirect) 246,677 shares and 986,708 options (direct)

Number disposed: N/A Value/Consideration: $124,335.40 No. of securities held after change: Ordinary shares–11,065,000 (indirect), 396,677 (direct) Options expiring 30 Aug 2010 at 25 cents each – 1,500,000 (indirect) and 986,708 (direct) Nature of the change: Rights Issue subscription

PART 2 – Change of director’s interests in contracts

Details of contract: None Applicable

Nature of interest: Name of registered holder: (if issued securities) No. and class of securities to which interest relates: Interest acquired: Interest disposed: Value/Consideration: Interest after change: